GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Other Long-Term Liabilities

Serina Therapeutics (Serina Therapeutics) Other Long-Term Liabilities : $-0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Other Long-Term Liabilities?

Serina Therapeutics's other long-term liabilities for the quarter that ended in Mar. 2024 was $-0.00 Mil.

Serina Therapeutics's quarterly other long-term liabilities declined from Dec. 2022 ($36.52 Mil) to Jun. 2023 ($36.06 Mil) and declined from Jun. 2023 ($36.06 Mil) to Mar. 2024 ($-0.00 Mil).

Serina Therapeutics's annual other long-term liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($36.40 Mil) and increased from Dec. 2021 ($36.40 Mil) to Dec. 2022 ($36.52 Mil).

Serina Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Serina Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Other Long-Term Liabilities Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Other Long-Term Liabilities
- -

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Other Long-Term Liabilities - - - - -

Serina Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Serina Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Other Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024